July 31, 2018 07:46 AM EDT

Revenue shrinking, Sanofi sweeps a PhII cancer ADC and TB vaccine program out of the pipeline in Q2 cleanup

A little more than a year ago Sanofi $SNY handed ImmunoGen a $30 million payment to gain exclusive development rights to a slate of …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Rev­enue shrink­ing, Sanofi sweeps a PhII can­cer ADC and TB vac­cine pro­gram out of the pipeline in Q2 cleanup